Raphael Pharmaceutical Inc. (OTCPK: RAPH)
Health Care · Biotechnology · IL
$—
— today · — 1Y
Raphael Pharmaceutical Inc. (OTCPK: RAPH) operates in the Biotechnology industry within the Health Care sector. The company is valued at $28.25M and employs 0 people.
trading between 0.04 and 1.40.
Tweenvest scores Raphael Pharmaceutical Inc. across four factors: quality 8/100. Its strongest factor is quality.
RAPH price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $28.25M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.05
- Dividend yield
- —
- Beta (5Y)
- 1.93
- 52-week high
- $1.40
- 52-week low
- $0.04
- Avg volume (3M)
- —
- Shares outstanding
- 20.18M
- Employees
- 0
- Next earnings
- —
About Raphael Pharmaceutical Inc.
Raphael Pharmaceutical Inc. operates as a biopharmaceutical firm, concentrating its efforts on discovering and clinically developing novel therapeutic solutions. These treatments primarily leverage cannabinoids and are designed to enhance patients' quality of life. Currently, the company's leading investigational drug candidate is being advanced for the management of rheumatoid arthritis. Furthermore, Raphael Pharma plans to broaden its pipeline to include more cannabinoid-based medicines aimed at various cancer types and other autoimmune conditions. The company's corporate headquarters are situated in Tel Aviv-Jaffa, Israel.
- ISIN
- US27785B2088
- Listed since
- Jan 5, 2023
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.